MARKET-DISCOVERED GROUP
Medical Technology
0 of 3 measured session-normalized paths align to the mixed across 1.3 effective names. Common-bar coverage spans 3 of 4 cohort members. Capital-flow agreement is 1%, so the basket is not yet clean. No verified headline preceded the measured move.
Broad move or one-stock disguise?
Observed movement is concentrated across 1.3 effective names. KMTS represents 85.5% of absolute path energy; 0 of 3 members align without a clean common direction.
01 · WHAT IS HAPPENING
The move, the flow and who is driving it
Observed session sequence
- KMTS moved higher firstFirst member to clear the material path threshold · path +0.87%
- MDXG registered a material lower path30m after the first price move · path -0.56%
Sequence inferred from aligned 5-minute price paths; it is not a causal ordering.
How the members are behaving together
Observed member paths normalized to the session. The dashed marker shows when the median move first cleared a material threshold; shading marks the latest 20% of the observed window.
02 · WHY IT MATTERS
Why now and where the move could travel
Verified recent context
No verified recent catalyst is attached to this move. The relationship may be market-led rather than news-led.
Shared filing context
No high-confidence shared filing driver is available. The market relationship is observed, but the cause remains unexplained.
Outsiders and cross-asset links
No qualified cross-asset lead/lag link is available for this group.
Filing-linked outsiders test whether the move is spreading beyond the established cohort.
03 · WHO IS IN IT
Member participation
4/4 active1 rising · 0 falling
View exact member values
| TICKER | Company | Role now | Today | Observed history | Trader interpretation |
|---|---|---|---|---|---|
| AVNS | Avanos Medical, Inc. | Most unusual | — | 75% of 4 sessions | Most unusual activity in this snapshot; performance direction may differ. |
| BLCO | Bausch + Lomb Corporation | Participating | +0.2% | 25% of 4 sessions | Price participation with accumulating signed flow. |
| MDXG | MiMedx Group, Inc | Participating | — | 75% of 4 sessions | Price participation with accumulating signed flow. |
| KMTS | Kestra Medical Technologies, Lt | Participating | — | 25% of 4 sessions | Price participation with accumulating signed flow. |
04 · HAS THIS HAPPENED BEFORE
Identity history versus measured outcomes
Live outcome ledger collecting
No completed point-in-time outcome is available yet. New live confirmations are now retained with their exact observation timestamp; statistics appear only after the corresponding candles complete.
Only 2 completed episodes across 4 active sessions; treat history as context, not a validated playbook. These episode counts describe recurrence; the outcome ledger above is the only forward-performance evidence.